Literature DB >> 3094604

Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines.

A J Furley, B R Reeves, S Mizutani, L J Altass, S M Watt, M C Jacob, P van den Elsen, C Terhorst, M F Greaves.   

Abstract

The cell line KG1 derived from a patient with erythroleukemia in myeloblastic relapse has the composite phenotype and functional repertoire of myeloblasts. In marked contrast, its subline KG1a has lost myeloid features, acquired new karyotypic markers, and has three characteristics associated with immature T cells: low-level expression of the T cell receptor beta mRNA (but not alpha) transcribed from a germline gene; high-level expression of T3 delta mRNA and intracellular, but not cell surface, T3 protein; and expression of the CD7/gp40 T cell-associated membrane antigen. Both KG1 and KG1a transcribe unrearranged IgH genes. These data suggest that either the KG1 cell line was derived from a common myeloid-lymphoid progenitor or that the KG1a subline phenotype is aberrant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094604

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Immunoglobulin heavy-chain and CD3 delta-chain gene enhancers are DNase I-hypersensitive in hemopoietic progenitor cells.

Authors:  A M Ford; C A Bennett; L E Healy; E Navarro; E Spooncer; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.

Authors:  Haiyan Qin; Qing Wu; John K Cowell; Mingqiang Ren
Journal:  Haematologica       Date:  2015-11-20       Impact factor: 9.941

3.  miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the BCL2L11 and BAX Proapoptotic Genes.

Authors:  Tianxiang Hu; Yating Chong; Sumin Lu; Rebecca Wang; Haiyan Qin; Jeane Silva; Eiko Kitamura; Chang-Sheng Chang; LesleyAnn Hawthorn; John K Cowell
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

4.  Development of analytical methods for multiplex bio-assay with inductively coupled plasma mass spectrometry.

Authors:  Olga I Ornatsky; Robert Kinach; Dmitry R Bandura; Xudong Lou; Scott D Tanner; Vladimir I Baranov; Mark Nitz; Mitchell A Winnik
Journal:  J Anal At Spectrom       Date:  2008       Impact factor: 4.023

5.  Cloning and characterization of the novel gene for mast cell carboxypeptidase A.

Authors:  D S Reynolds; D S Gurley; K F Austen
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

6.  The importance of molecular cytogenetic analysis prior to using cell lines in research: The case of the KG-1a leukemia cell line.

Authors:  Franca Pelliccia; Valentina Ubertini; Nazario Bosco
Journal:  Oncol Lett       Date:  2012-05-09       Impact factor: 2.967

7.  Preparation of Proper Immunogen by Cloning and Stable Expression of cDNA coding for Human Hematopoietic Stem Cell Marker CD34 in NIH-3T3 Mouse Fibroblast Cell Line.

Authors:  Farzaneh Shafaghat; Hajar Abbasi-Kenarsari; Jafar Majidi; Ali Akbar Movassaghpour; Dariush Shanehbandi; Tohid Kazemi
Journal:  Adv Pharm Bull       Date:  2015-03-05

8.  Multiple layers of transcriptional regulation by PLZF in NKT-cell development.

Authors:  Ai-Ping Mao; Michael G Constantinides; Rebecca Mathew; Zhixiang Zuo; Xiaoting Chen; Matthew T Weirauch; Albert Bendelac
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

9.  Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome.

Authors:  Kevin K Leung; Aaron Nguyen; Tao Shi; Lin Tang; Xiaochun Ni; Laure Escoubet; Kyle J MacBeth; Jorge DiMartino; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-24       Impact factor: 11.205

10.  Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.

Authors:  Ying Ye; Michael A McDevitt; Mingzhou Guo; Wei Zhang; Oliver Galm; Steven D Gore; Judith E Karp; Jaroslaw P Maciejewski; Jeanne Kowalski; Hua-Ling Tsai; Lukasz P Gondek; Hsing-Chen Tsai; Xiaofei Wang; Craig Hooker; B Douglas Smith; Hetty E Carraway; James G Herman
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.